Insights on Life Sciences
Article
Closing the women’s health gap: Biopharma’s untapped opportunity
-
Most top pharma companies derive more than 60 percent of their revenue from therapies for diseases that affect women uniquely, differently, or disproportionately, putting them in a prime position to close the sex- and gender-based health gap.
Podcast
Genentech’s John Marioni on enhancing drug discovery with data and AI
-
John Marioni discusses how he and his teams across industries and academia use evolving technologies to bring increasingly sophisticated...
Article
Scaling gen AI in the medtech industry
-
Medtech leaders can fully unleash gen AI by selecting key domains and workflows for transformation and aligning business and...
Article
Too big to succeed? Unlocking value in large medtechs
-
Diversified medtech giants have struggled to match the shareholder returns of other sectors, but targeted strategies can unlock...
Podcast
J&J’s Ashita Batavia on advancing oncology clinical-trials with data
-
Ashita Batavia, head of hematology and oncology data sciences, R&D, at Johnson & Johnson Innovative Medicine, discusses...
Special collection
RewiR&D: Making more medicines that matter
A selection of recently published articles that offer practical solutions to biopharmaceutical innovation challenges. Together, these articles provide a recipe to boost R&D productivity and accelerate the development of lifesaving therapies.
Future of pharma operations
Pharma companies are experiencing a wave of innovations – from new treatment modalities, to smart machines, advanced analytics, and digital connectivity. This selection of articles presents strategies and insights to capitalize on these innovations and advance quality, efficiency, resilience, and workforce agility in pharma operations.
McKinsey insights on cell and gene therapy
Continuing advances in cell and gene therapy (CGT) are transforming how biopharma companies treat and potentially cure certain diseases. Browse our collection of articles for an in-depth look at the opportunities, challenges, and implications for stakeholders in this fast-evolving field, and explore how McKinsey’s new Digital Capability Center for Cell and Gene Therapy will help biopharma companies accelerate digital transformations in manufacturing and the journey to operational excellence. Contact us to learn more.